Treatment beyond progression with chemo-immunotherapy in an advanced esophageal squamous cell carcinoma patient: a case report

Esophageal cancer is an aggressive and common malignancy in Asian countries. Due to late diagnosis and limited treatments, the prognosis of esophageal cancer is still very poor. Although immune checkpoint inhibitors have become promising second-line treatments for esophageal cancer, there are limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Ping, Xiao, Yajie, Zhao, Zhikun, Sun, Chao, Wu, Dongfang, Chen, Yuan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798522/
https://www.ncbi.nlm.nih.gov/pubmed/35116347
http://dx.doi.org/10.21037/tcr-21-1395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798522/
https://www.ncbi.nlm.nih.gov/pubmed/35116347
http://dx.doi.org/10.21037/tcr-21-1395

Ejemplares similares